Results 211 to 220 of about 165,400 (311)

Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease

JPGN Reports, EarlyView.
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons, Lindsey Lawrence, Samantha Saul   +2 more
wiley   +1 more source

Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. [PDF]

Int J Mol Sci
Teschke R.
europepmc   +1 more source

The Complex Role of IL‐13 in Bullous Pemphigoid: New Insights From a Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, primarily affecting the elderly. The role of interleukin‐13 (IL‐13) in BP pathogenesis remains unclear, particularly regarding its potential as a therapeutic target.
Marwan Dawood, Zenab Ali Saleh, Ilanit Boyango, Orna Mirmovich Morvay, Salih Mishlab, Ziad Khamaysi, Emily Avitan‐Hersh   +6 more
wiley   +1 more source

Gout flares following acute stroke: a single-center cohort and a systematic review/meta-analysis. [PDF]

Neurol Res Pract
Panagiotopoulos E, Kotsali-Peteinelli V, Papagiannopoulou G, Theodorou A, Chondrogianni M, Bakola E, Palaiodimou L, Psychogios K, Kargiotis O, Safouris A, Tsalouchidou PE, Mengel A, Ziemann U, Krogias C, Tsivgoulis G, Stefanou MI.   +15 more
europepmc   +1 more source

Biological damage due to photospheric, chromospheric and flare radiation in the environments of main-sequence stars [PDF]

, 2009
Manfred Cuntz, Edward F. Guinan, Robert L. Kurucz, Manfred Cuntz, Edward F. Guinan   +4 more
openalex   +1 more source

Long‐Term Real‐World Effectiveness of Rupatadine in Chronic Urticaria: A Retrospective Observational Study

JEADV Clinical Practice, EarlyView.
This retrospective observational study analyzed a cohort of chronic urticaria (CU) patients to provide insight into the clinical practice of CU with second‐generation antihistamines (SgAHs) and to evaluate the long‐term real‐world effectiveness of rupatadine in CU. Patients with chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU)
A. M. Giménez‐Arnau, C. Romero, M. March, A. Tomas, I. Izquierdo, R. M. Pujol   +5 more
wiley   +1 more source

The impact social support and its different types have upon Crohn's disease: a double, case-control study on patients experiencing a flare-up or in remission, and healthy individuals. [PDF]

Therap Adv Gastroenterol
de Dios Duarte MJ, Arias A, Brea Iglesias J, de la Osa Subtil I, Barrón A.   +4 more
europepmc   +1 more source

It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis [PDF]

, 2015
Anna R. Moverley, Karen Vinall‐Collier, Philip Helliwell   +2 more
openalex   +1 more source

Association of Short‐Term Wildfire Air Pollution Exposure and Health Care Usage: A Cross‐Sectional Study Among Patients With Psoriasis From the Bay Area, United States

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Wildfire air pollution causes many adverse environmental and health effects, including adverse skin reactions. However, whether wildfire‐associated air pollution and psoriasis disease activity are associated remains unknown. Objectives To examine the association between short‐term exposure to air pollution from wildfires and rates ...
Johan Anker Chrom Allerup, Somaia Naassan, Zarqa Ali, Justin M. Ko, Kenneth Thomsen, Simon Francis Thomsen   +5 more
wiley   +1 more source

A Narrative Review of Phase II and III Clinical Trials for the Pharmacological Treatment of Fibrodysplasia Ossificans Progressiva (FOP): Efficacy, Safety, and Challenges in Treatment Strategies. [PDF]

Drug Des Devel Ther
Alharthi MS.
europepmc   +1 more source